• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤和治疗相关因素对充分手术治疗后骨肉瘤局部复发的影响。对新辅助合作骨肉瘤研究组方案治疗的 1355 例患者的分析。

The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

机构信息

Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Academic Teaching Hospital of the Charité Universitätsmedizin, Berlin.

Pediatrics 5-Oncology, Hematology and Immunology, COSS Study Center, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.

出版信息

Ann Oncol. 2011 May;22(5):1228-1235. doi: 10.1093/annonc/mdq589. Epub 2010 Oct 28.

DOI:10.1093/annonc/mdq589
PMID:21030381
Abstract

BACKGROUND

Local recurrence (LR) in osteosarcoma is associated with very poor prognosis. We sought to evaluate which factors correlate with LR in patients who achieved complete surgical remission with adequate margins.

PATIENTS AND METHODS

We analyzed 1355 patients with previously untreated high-grade central osteosarcoma of the extremities, the shoulder and the pelvis registered in neoadjuvant Cooperative Osteosarcoma Study Group trials between 1986 and 2005. Seventy-six patients developed LR.

RESULTS

Median follow-up was 5.56 years. No participation in a study, pelvic tumor site, limb-sparing surgery, soft tissue infiltration beyond the periosteum, poor response to neoadjuvant chemotherapy, failure to complete the planned chemotherapy protocol and biopsy at a center other than the one performing the tumor resection were significantly associated with a higher LR rate. No differences were found for varying surgical margin widths. Surgical treatment at centers with small patient volume and additional surgery in the primary tumor area, other than biopsy and tumor resection, were significantly associated with a higher rate of ablative surgery.

CONCLUSIONS

Patient enrollment in clinical trials and performing the biopsy at experienced institutions capable of undertaking the tumor resection without compromising the oncological and functional outcome should be pursued in the future.

摘要

背景

骨肉瘤的局部复发与非常差的预后相关。我们试图评估在达到完全手术缓解且切缘足够的患者中,哪些因素与局部复发相关。

患者与方法

我们分析了 1986 年至 2005 年期间新辅助合作骨肉瘤研究组试验中登记的 1355 例先前未经治疗的四肢、肩部和骨盆高级别中心性骨肉瘤患者。76 例患者发生局部复发。

结果

中位随访时间为 5.56 年。未参与研究、骨盆肿瘤部位、保肢手术、骨膜外软组织浸润、对新辅助化疗的反应不良、未能完成计划的化疗方案以及在除进行肿瘤切除的中心之外的其他中心进行活检与更高的局部复发率显著相关。手术切缘宽度的变化与局部复发率无差异。在患者数量较少的中心进行手术治疗,以及在除活检和肿瘤切除之外的原发性肿瘤区域进行额外手术,与根治性手术的更高发生率显著相关。

结论

未来应追求将患者纳入临床试验,并在有经验的机构进行活检,这些机构有能力在不影响肿瘤学和功能结果的情况下进行肿瘤切除。

相似文献

1
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.肿瘤和治疗相关因素对充分手术治疗后骨肉瘤局部复发的影响。对新辅助合作骨肉瘤研究组方案治疗的 1355 例患者的分析。
Ann Oncol. 2011 May;22(5):1228-1235. doi: 10.1093/annonc/mdq589. Epub 2010 Oct 28.
2
A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.一种用于原发性高级别骨肉瘤手术分期的新系统:伯明翰分类法。
Clin Orthop Relat Res. 2017 Mar;475(3):842-850. doi: 10.1007/s11999-016-4851-y.
3
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.原发性转移性骨肉瘤:接受新辅助骨肉瘤协作研究组方案治疗患者的表现及预后
J Clin Oncol. 2003 May 15;21(10):2011-8. doi: 10.1200/JCO.2003.08.132.
4
Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.局部复发对接受新辅助化疗的肢体骨肉瘤患者生存的影响:一家机构对44例患者的经验。
Cancer. 2006 Jun 15;106(12):2701-6. doi: 10.1002/cncr.21937.
5
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?骨肉瘤局部复发后化疗有作用吗?
Pediatr Blood Cancer. 2019 Aug;66(8):e27792. doi: 10.1002/pbc.27792. Epub 2019 May 6.
6
Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?新辅助化疗后延迟手术:所有非转移性高级骨盆骨肉瘤患者都需要吗?
Clin Orthop Relat Res. 2018 Nov;476(11):2177-2186. doi: 10.1097/CORR.0000000000000387.
7
Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.MRI 上的肿瘤近端位置和液-液平面与 IIB 期骨肉瘤的化疗耐药性相关。
Clin Orthop Relat Res. 2014 Jun;472(6):1911-20. doi: 10.1007/s11999-014-3521-1. Epub 2014 Feb 27.
8
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.新辅助化疗治疗肢体骨肉瘤的预后因素:单机构789例患者的15年经验
Cancer. 2006 Mar 1;106(5):1154-61. doi: 10.1002/cncr.21724.
9
Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma.骨肉瘤患者行根治性手术和保肢手术后的局部和全身控制情况。
Clin Orthop Relat Res. 1999 Jan(358):120-7.
10
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.四肢或躯干高级别骨肉瘤的预后因素:对1702例接受新辅助治疗的骨肉瘤协作研究组方案患者的分析
J Clin Oncol. 2002 Feb 1;20(3):776-90. doi: 10.1200/JCO.2002.20.3.776.

引用本文的文献

1
Surgical Margin Analysis in Osteosarcoma: Impact on Survival and Local Control.骨肉瘤手术切缘分析:对生存及局部控制的影响
Cancers (Basel). 2025 Aug 6;17(15):2581. doi: 10.3390/cancers17152581.
2
Early diagnosis and treatment of low-grade myofibroblastic sarcoma in the left distal femur: a case report and literature review.左股骨远端低度恶性肌成纤维细胞肉瘤的早期诊断与治疗:一例报告及文献复习
BMC Musculoskelet Disord. 2025 Jul 7;26(1):662. doi: 10.1186/s12891-025-08565-4.
3
[Basic principles of the diagnostics and treatment of malignant bone tumors in old age].
[老年恶性骨肿瘤的诊断与治疗基本原则]
Orthopadie (Heidelb). 2025 Oct;54(10):825-833. doi: 10.1007/s00132-025-04667-y. Epub 2025 Jul 2.
4
Pain Accelerates, Swelling and Sensory Disturbances Delay Diagnosis in Mesenchymal Tumors.疼痛会加速间叶组织肿瘤的诊断,而肿胀和感觉障碍则会延迟诊断。
Cancers (Basel). 2025 Feb 3;17(3):510. doi: 10.3390/cancers17030510.
5
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.推进研究和治疗的生物样本采集:通过欧洲研究和欧洲尤因肉瘤联盟声明对抗骨肉瘤。
Clin Cancer Res. 2024 Aug 15;30(16):3395-3406. doi: 10.1158/1078-0432.CCR-24-0101.
6
Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS).骨肉瘤协作研究组(COSS)的组建、维持及成效
Cancers (Basel). 2023 Feb 28;15(5):1520. doi: 10.3390/cancers15051520.
7
Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma.骨肉瘤新辅助化疗的预后因素及组织病理学反应分析。
Jt Dis Relat Surg. 2023;34(1):196-206. doi: 10.52312/jdrs.2023.902. Epub 2023 Jan 14.
8
Application of interpretable machine learning algorithms to predict distant metastasis in osteosarcoma.可解释机器学习算法在预测骨肉瘤远处转移中的应用。
Cancer Med. 2023 Feb;12(4):5025-5034. doi: 10.1002/cam4.5225. Epub 2022 Sep 9.
9
Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS).术前被误诊为其他肿瘤的骨肉瘤:来自骨肉瘤协作研究组(COSS)的报告
J Cancer Res Clin Oncol. 2023 May;149(5):1961-1967. doi: 10.1007/s00432-022-04156-1. Epub 2022 Aug 18.
10
Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children.系统免疫炎症指数对儿童骨肉瘤癌特异性生存的预测价值。
Front Public Health. 2022 Jul 27;10:879523. doi: 10.3389/fpubh.2022.879523. eCollection 2022.